Clinical Characteristics and Early Management Outcomes of Neonatal Respiratory Distress Syndrome

Authors

  • Michael Kidd

Keywords:

Neonatal Respiratory Distress Syndrome, Prematurity, Pulmonary Surfactant Deficiency, Neonatal Respiratory Failure, Continuous Positive Airway Pressure, Surfactant Replacement Therapy, Neonatal Intensive Care, Bronchopulmonary Dysplasia, Mechanical Ventilation, Neonatal Clinical Outcomes

Abstract

Neonatal respiratory distress syndrome (NRDS) is a major respiratory disorder affecting premature newborns and is associated with pulmonary surfactant deficiency, reduced lung compliance, impaired gas exchange, and increased respiratory effort. The condition remains an important cause of neonatal respiratory failure, particularly among infants born at extremely low gestational ages. Early recognition and appropriate management are essential for improving survival, reducing respiratory complications, and supporting long-term pulmonary development. This narrative review evaluates the clinical characteristics, diagnostic considerations, risk factors, early therapeutic interventions, and management outcomes associated with neonatal respiratory distress syndrome. Evidence from randomized controlled trials, systematic reviews, and international consensus guidelines indicates that antenatal corticosteroids, early noninvasive respiratory support, selective surfactant replacement, and lung-protective ventilation can improve selected neonatal outcomes. Nevertheless, the effectiveness of individual interventions varies according to gestational age, disease severity, treatment timing, and available neonatal intensive care resources. Early continuous positive airway pressure can reduce exposure to invasive ventilation, while less invasive surfactant administration offers potential benefits for selected preterm infants. Important complications include pneumothorax, bronchopulmonary dysplasia, respiratory failure, and mortality. The review emphasizes the importance of timely diagnosis, individualized respiratory support, careful oxygen monitoring, and multidisciplinary neonatal care. Evidence-based early management can improve respiratory stabilization while reducing treatment-related lung injury in premature newborns.

Views: 0Downloads: 0

Downloads

Download data is not yet available.

References

Dargaville, P. A., Kamlin, C. O. F., Orsini, F., et al. (2021). Effect of minimally invasive surfactant therapy vs sham treatment on death or bronchopulmonary dysplasia in preterm infants with respiratory distress syndrome: The OPTIMIST-A randomized clinical trial. JAMA, 326(24), 2478–2487. https://doi.org/10.1001/jama.2021.21892

Kanmaz, H. G., Erdeve, O., Canpolat, F. E., Mutlu, B., & Dilmen, U. (2013). Surfactant administration via thin catheter during spontaneous breathing: Randomized controlled trial. Pediatrics, 131(2), e502–e509. https://doi.org/10.1542/peds.2012-0603

Kribs, A., Roll, C., Göpel, W., et al. (2015). Nonintubated surfactant application vs conventional therapy in extremely preterm infants: A randomized clinical trial. JAMA Pediatrics, 169(8), 723–730. https://doi.org/10.1001/jamapediatrics.2015.0504

Lemyre, B., Deguise, M.-O., Benson, P., Kirpalani, H., Ekhaguere, O. A., & Davis, P. G. (2023a). Early nasal intermittent positive pressure ventilation (NIPPV) versus early nasal continuous positive airway pressure (NCPAP) for preterm infants. Cochrane Database of Systematic Reviews, 2023(7), CD005384. https://doi.org/10.1002/14651858.CD005384.pub3

Lemyre, B., Deguise, M.-O., Benson, P., Kirpalani, H., De Paoli, A. G., & Davis, P. G. (2023b). Nasal intermittent positive pressure ventilation (NIPPV) versus nasal continuous positive airway pressure (NCPAP) for preterm neonates after extubation. Cochrane Database of Systematic Reviews, 2023(7), CD003212. https://doi.org/10.1002/14651858.CD003212.pub4

McGoldrick, E., Stewart, F., Parker, R., & Dalziel, S. R. (2020). Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database of Systematic Reviews, 2020(12), CD004454. https://doi.org/10.1002/14651858.CD004454.pub4

Morley, C. J., Davis, P. G., Doyle, L. W., Brion, L. P., Hascoet, J.-M., & Carlin, J. B. (2008). Nasal CPAP or intubation at birth for very preterm infants. The New England Journal of Medicine, 358(7), 700–708. https://doi.org/10.1056/NEJMoa072788

Oei, J. L., Vento, M., Rabi, Y., Wright, I., Finer, N., Rich, W., Kapadia, V., Aune, D., Rook, D., Tarnow-Mordi, W., & Saugstad, O. D. (2017). Higher or lower oxygen for delivery room resuscitation of preterm infants below 28 completed weeks gestation: A meta-analysis. Archives of Disease in Childhood - Fetal and Neonatal Edition, 102(1), F24–F30. https://doi.org/10.1136/archdischild-2016-310435

Reuter, S., Moser, C., & Baack, M. (2014). Respiratory distress in the newborn. Pediatrics in Review, 35(10), 417–428. https://doi.org/10.1542/pir.35-10-417

Roberts, C. T., Owen, L. S., Manley, B. J., Frøisland, D. H., Donath, S. M., Dalziel, K. M., Pritchard, M. A., Cartwright, D. W., Collins, C. L., Malhotra, A., & Davis, P. G. (2016). Nasal high-flow therapy for primary respiratory support in preterm infants. The New England Journal of Medicine, 375(12), 1142–1151. https://doi.org/10.1056/NEJMoa1603694

Schmidt, B., Roberts, R. S., Davis, P., Doyle, L. W., Barrington, K. J., Ohlsson, A., Solimano, A., & Tin, W. (2006). Caffeine therapy for apnea of prematurity. The New England Journal of Medicine, 354(20), 2112–2121. https://doi.org/10.1056/NEJMoa054065

Schmölzer, G. M., Kumar, M., Pichler, G., Aziz, K., O'Reilly, M., & Cheung, P.-Y. (2013). Non-invasive versus invasive respiratory support in preterm infants at birth: Systematic review and meta-analysis. BMJ, 347, f5980. https://doi.org/10.1136/bmj.f5980

SUPPORT Study Group of the Eunice Kennedy Shriver NICHD Neonatal Research Network. (2010). Early CPAP versus surfactant in extremely preterm infants. The New England Journal of Medicine, 362(21), 1970–1979. https://doi.org/10.1056/NEJMoa0911783

Sweet, D. G., Carnielli, V. P., Greisen, G., Hallman, M., Klebermass-Schrehof, K., Lavizzari, A., Ozek, E., Te Pas, A., Roehr, C. C., Saugstad, O. D., Simeoni, U., Vento, M., Visser, G. H. A., & Speer, C. P. (2026). European consensus guidelines on the management of respiratory distress syndrome: 2025. Neonatology, 123(4), 514–539. https://doi.org/10.1159/000551062

Verder, H., Robertson, B., Greisen, G., Ebbesen, F., Albertsen, P., Lundstrøm, K., & Jacobsen, T. (1994). Surfactant therapy and nasal continuous positive airway pressure for newborns with respiratory distress syndrome. The New England Journal of Medicine, 331(16), 1051–1055. https://doi.org/10.1056/NEJM199410203311603

Condò, V., Cipriani, S., Colnaghi, M., Bellù, R., Zanini, R., Bulfoni, C., Parazzini, F., & Mosca, F. (2017). Neonatal respiratory distress syndrome: Are risk factors the same in preterm and term infants? The Journal of Maternal-Fetal & Neonatal Medicine, 30(11), 1267–1272. https://doi.org/10.1080/14767058.2016.1210597

Shin, J., Choi, C. W., & Lee, B. K. (2024). Risk factors for refractory respiratory distress syndrome among very-low-birth-weight infants. BMC Pediatrics, 24, Article 677. https://doi.org/10.1186/s12887-024-05138-7

Yenuberi, H., Ross, B., Tirkey, R. S., Benjamin, S. J., Rathore, S., Karuppusami, R., Lal, A., Thomas, N., & Mathew, J. E. (2024). Late-preterm antenatal steroids for reduction of neonatal respiratory complications: A randomized controlled trial. Obstetrics & Gynecology, 143(4), 468–474. https://doi.org/10.1097/AOG.0000000000005520

Soll, R. F., & Lucey, J. F. (1991). Surfactant replacement therapy. Pediatrics in Review, 12(9), 261–267. https://doi.org/10.1542/pir.12-9-261

Pang, H., Zhang, B., Shi, J., Zang, J., & Qiu, L. (2019). Diagnostic value of lung ultrasound in evaluating the severity of neonatal respiratory distress syndrome. European Journal of Radiology, 116, 186–191. https://doi.org/10.1016/j.ejrad.2019.05.004

Ismail, R., El Raggal, N. M., Hegazy, L. A., Sakr, H. M., Eldafrawy, O. A., & Farid, Y. A. (2023). Lung ultrasound role in diagnosis of neonatal respiratory disorders: A prospective cross-sectional study. Children, 10(1), Article 173. https://doi.org/10.3390/children10010173

Sefic Pasic, I., Riera Soler, L., Vazquez Mendez, E., & Castillo Salinas, F. (2023). Comparison between lung ultrasonography and chest X-ray in the evaluation of neonatal respiratory distress syndrome. Journal of Ultrasound, 26(2), 435–448. https://doi.org/10.1007/s40477-022-00728-6

De Martino, L., Yousef, N., Ben-Ammar, R., Raimondi, F., Shankar-Aguilera, S., & De Luca, D. (2018). Lung ultrasound score predicts surfactant need in extremely preterm neonates. Pediatrics, 142(3), e20180463. https://doi.org/10.1542/peds.2018-0463

SUPPORT Study Group of the Eunice Kennedy Shriver NICHD Neonatal Research Network. (2010). Early CPAP versus surfactant in extremely preterm infants. The New England Journal of Medicine, 362(21), 1970–1979. https://doi.org/10.1056/NEJMoa0911783

Roberts, C. T., Owen, L. S., Manley, B. J., Frøisland, D. H., Donath, S. M., Dalziel, K. M., Pritchard, M. A., Cartwright, D. W., Collins, C. L., Malhotra, A., & Davis, P. G. (2016). Nasal high-flow therapy for primary respiratory support in preterm infants. The New England Journal of Medicine, 375(12), 1142–1151. https://doi.org/10.1056/NEJMoa1603694

Manley, B. J., Owen, L. S., Doyle, L. W., Andersen, C. C., Cartwright, D. W., Pritchard, M. A., Donath, S. M., & Davis, P. G. (2013). High-flow nasal cannulae in very preterm infants after extubation. The New England Journal of Medicine, 369(15), 1425–1433. https://doi.org/10.1056/NEJMoa1300071

Hodgson, K. A., Wilkinson, D., De Paoli, A. G., & Manley, B. J. (2023). Nasal high flow therapy for primary respiratory support in preterm infants. Cochrane Database of Systematic Reviews, 2023(5), CD006405. https://doi.org/10.1002/14651858.CD006405.pub4

Göpel, W., Kribs, A., Ziegler, A., Laux, R., Hoehn, T., Wieg, C., Siegel, J., Avenarius, S., von der Wense, A., Vochem, M., Groneck, P., Weller, U., Möller, J., Härtel, C., Haller, S., Roth, B., & Herting, E. (2011). Avoidance of mechanical ventilation by surfactant treatment of spontaneously breathing preterm infants (AMV): An open-label, randomised, controlled trial. The Lancet, 378(9803), 1627–1634. https://doi.org/10.1016/S0140-6736(11)60986-0

Dargaville, P. A., Kamlin, C. O. F., Orsini, F., Wang, X., De Paoli, A. G., Kanmaz Kutman, H. G., Cetinkaya, M., Kornhauser-Cerar, L., Derrick, M., Özkan, H., Hulzebos, C. V., Schmölzer, G. M., Aiyappan, A., Lemyre, B., Kuo, S., Rajadurai, V. S., O'Shea, J., Biniwale, M., Ramanathan, R., ... Davis, P. G. (2021). Effect of minimally invasive surfactant therapy vs sham treatment on death or bronchopulmonary dysplasia in preterm infants with respiratory distress syndrome: The OPTIMIST-A randomized clinical trial. JAMA, 326(24), 2478–2487. https://doi.org/10.1001/jama.2021.21892

Silveira, R. C., Panceri, C., Munõz, N. P., Carvalho, M. B., Fraga, A. C., & Procianoy, R. S. (2024). Less invasive surfactant administration versus intubation-surfactant-extubation in the treatment of neonatal respiratory distress syndrome: A systematic review and meta-analyses. Jornal de Pediatria, 100(1), 8–24. https://doi.org/10.1016/j.jped.2023.05.008

Ramaswamy, V. V., Bandyopadhyay, T., Abiramalatha, T., Pullattayil S, A. K., Szczapa, T., Wright, C. J., & Roehr, C. C. (2023). Clinical decision thresholds for surfactant administration in preterm infants: A systematic review and network meta-analysis. eClinicalMedicine, 62, 102097. https://doi.org/10.1016/j.eclinm.2023.102097

Schmidt, B., Roberts, R. S., Davis, P., Doyle, L. W., Barrington, K. J., Ohlsson, A., Solimano, A., & Tin, W. (2006). Caffeine therapy for apnea of prematurity. The New England Journal of Medicine, 354(20), 2112–2121. https://doi.org/10.1056/NEJMoa054065

Bassler, D., et al. (2015). Early inhaled budesonide for the prevention of bronchopulmonary dysplasia. The New England Journal of Medicine, 373(16), 1497–1506. https://doi.org/10.1056/NEJMoa1501917

Pérez-Tarazona, S., Marset, G., Part, M., López, C., & Pérez-Lara, L. (2022). Definitions of bronchopulmonary dysplasia: Which one should we use? The Journal of Pediatrics, 251, 67–73.e2. https://doi.org/10.1016/j.jpeds.2022.05.037

Katz, T. A., Bancalari, E., Gordijn, S. J., Higgins, R. D., Isayama, T., Jensen, E. A., Offringa, M., Pillow, J. J., Shah, P. S., Soll, R. F., Stoecklin, B., Mugie, S. M., van Kaam, A. H., & Onland, W. (2026). Toward a harmonized bronchopulmonary dysplasia definition: An international Delphi process. Pediatrics, 157(5), e2025074308. https://doi.org/10.1542/peds.2025-074308

Sweet, D. G., Carnielli, V. P., Greisen, G., Hallman, M., Klebermass-Schrehof, K., Lavizzari, A., Ozek, E., Te Pas, A., Roehr, C. C., Saugstad, O. D., Simeoni, U., Vento, M., Visser, G. H. A., & Speer, C. P. (2026). European consensus guidelines on the management of respiratory distress syndrome: 2025. Neonatology, 123(4), 514–539. https://doi.org/10.1159/000551062

Sweet, D. G., Carnielli, V. P., Greisen, G., Hallman, M., Klebermass-Schrehof, K., Ozek, E., Te Pas, A., Plavka, R., Roehr, C. C., Saugstad, O. D., Simeoni, U., Speer, C. P., Vento, M., Visser, G. H. A., & Halliday, H. L. (2023). European consensus guidelines on the management of respiratory distress syndrome: 2022 update. Neonatology, 120(1), 3–23. https://doi.org/10.1159/000528914

Liu, J., Inchingolo, R., Suryawanshi, P., Guo, B.-B., Kurepa, D., González Cortés, R., Yan, W., Chi, J.-H., Acosta, C. M., Jagła, M., Sharma, D., Sorantin, E., Hsieh, K.-S., Graziani, G., Malta, B., Woods, P., Meng, Q., You, C.-M., Kruczek, P., ... Feletti, F. (2025). Guidelines for the use of lung ultrasound to optimise the management of neonatal respiratory distress: International expert consensus. BMC Medicine, 23, Article 114. https://doi.org/10.1186/s12916-025-03879-5

Sweet, D. G., Carnielli, V., Greisen, G., Hallman, M., Ozek, E., Te Pas, A., Plavka, R., Roehr, C. C., Saugstad, O. D., Simeoni, U., Speer, C. P., Vento, M., Visser, G. H. A., & Halliday, H. L. (2019). European consensus guidelines on the management of respiratory distress syndrome: 2019 update. Neonatology, 115(4), 432–450. https://doi.org/10.1159/000499361

Downloads

Published

2022-08-31

How to Cite

Michael Kidd. (2022). Clinical Characteristics and Early Management Outcomes of Neonatal Respiratory Distress Syndrome. Birat Journal of Health Sciences, 8(2), 1-14. https://www.bjhsnepal.org/index.php/bjhs/article/view/105